EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer

Sharuya Kulatheivam, Lea Lecanda Mariager Jakobsen, Mark Burton, Alan P Ainsworth, Claus Fristrup, Martin Graversen, Michael B Mortensen, Per Pfeiffer, Line S Tarpgaard, Sönke Detlefsen

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Sharuya Kulatheivam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Odense University Hospital, Odense, Denmark; Odense Pancreas Center (OPAC) and Odense PIPAC Center (OPC), Odense University …. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Ascitic Fluid, RNA, Messenger, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with peritoneal metastasis (PM) have poor survival rates, and few methods for prognostic stratification of patients with proven PM exist. Peritoneal fluid (PF) provides a direct reflection of the microenvironment of the peritoneal cavity, and transcriptomic profiling of PF represents a novel and potentially clinically valuable approach that warrants investigation. We aimed to evaluate the utility of formalin-fixed paraffin embedded (FFPE) PF sediments left over after conventional peritoneal cytology diagnosis for multiplexed mRNA expression profiling and to identify dysregulated mRNAs in PM vs. controls. Furthermore, we explored whether certain mRNAs upregulated in PM hold prognostic value. METHODS: Samples included were FFPE sediments of malignant PFs from cases of PM from pancreatic cancer (PM-PC, n = 19) scheduled for pressurized intraperitoneal aerosol chemotherapy (PIPAC) and benign ascites (controls, n = 16). RNA was extracted from the FFPE sediments. Expression profiling of 760 cancer-related mRNAs was performed, followed by unsupervised clustering, differential gene expression analysis, ROC/AUC analysis, generation of KM plots, and Cox proportional hazards regression. Cellular expression of proteins encoded by selected dysregulated mRNAs was analyzed using immunocytochemistry. RESULTS: In PF sediments with malignant cells, 56 upregulated and 130 downregulated mRNAs were identified. Selected up- and downregulated mRNAs were similarly dysregulated at the protein level. Upregulation of six mRNAs (ESRP2, EPCAM, SFN, ITGB6, ESRP1, and GRHL2) was associated with short-term survival (P < 0.0025). CONCLUSION: Our data indicate that PF from PM-PC patients is suitable for transcriptomic analysis. Numerous upregulated mRNAs known to play a role in tumour progression were identified. Our data indicate that mRNA profiling may be a clinically useful tool for further prognostic stratification of patients with proven PM, but larger studies are needed to validate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsAscitic FluidRNA, MessengerPancreatic NeoplasmsGene Expression ProfilingBiomarkers, TumorHumansFemaleMaleMiddle AgedAgedPrognosisTranscriptomeAdult

Stichwörter der Autor:innen

Pancreatic cancerPeritoneal lavagePeritoneal metastasisPressurized intraperitoneal aerosol chemotherapy (PIPAC)RNA profilingTranscriptomics

Substanzen

RNA, MessengerBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Odense University Hospital, Odense, Denmark; Odense Pancreas Center (OPAC) and Odense PIPAC Center (OPC), Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Clinical Genome Center, Univers…
  • Odense Pancreas Center (OPAC) and Odense PIPAC Center (OPC), Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Dep…
  • Odense Pancreas Center (OPAC) and Odense PIPAC Center (OPC), Odense University Hospital, Odense, Denmark; Department of Surgery, Upper GI and HPB Section, Odense University Hospital, Odense, Denmark.
  • Odense Pancreas Center (OPAC) and Odense PIPAC Center (OPC), Odense University Hospital, Odense, Denmark; Department of Surgery, Upper GI and HPB Section, Odense University Hospital, Odense, Denmark; OPEN - Open Patient…
  • Department of Pathology, Odense University Hospital, Odense, Denmark; Odense Pancreas Center (OPAC) and Odense PIPAC Center (OPC), Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of…

Zitieren

APA

Kulatheivam, S., Jakobsen, L. L. M., Burton, M., Ainsworth, A. P., Fristrup, C., Graversen, M., Mortensen, M. B., Pfeiffer, P., Tarpgaard, L. S., & Detlefsen, S. (2025). Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156250

Vancouver

Kulatheivam S, Jakobsen LLM, Burton M, Ainsworth AP, Fristrup C, Graversen M, et al. Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156250

BibTeX
@article{Kulatheivam2025,
  author = {Kulatheivam, Sharuya and Jakobsen, Lea Lecanda Mariager and Burton, Mark and Ainsworth, Alan P and Fristrup, Claus and Graversen, Martin and Mortensen, Michael B and Pfeiffer, Per and Tarpgaard, Line S and Detlefsen, Sönke},
  title = {Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156250}
}
Kostenlos starten →